Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Somsundaram Chettiar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Discovery|November 1, 2016
Current challenges in drug discovery for tuberculosisAnuradha Kumar, Somsundaram Chettiar, Tanya Parish
Access Microbiology|September 25, 2020
Cell wall inhibitors increase the accumulation of rifampicin in <i>Mycobacterium tuberculosis</i>Matthew B McNeil, Somsundaram Chettiar, Divya Awasthi, et al.
Anticancer Research|May 29, 2017
Structure-Activity Relationship of Niclosamide DerivativesZhonghai Tang, Ulyana Muñoz Acuña, Nelson Freitas Fernandes, et al.
Microbiology Spectrum|January 23, 2023
Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosisShilah Bonnett, Jo-Ann Jee, Somsundaram Chettiar, et al.
Bioorganic & Medicinal Chemistry|March 6, 2017
Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancerYasuro Sugimoto, Dwitiya B Sawant, Harold A Fisk, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2015
Niclosamide Analogs for Treatment of Ovarian CancerChristen L Walters Haygood, Rebecca C Arend, Abhishek Gangrade, et al.
ACS Infectious Diseases|October 17, 2017
Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrBN Susantha Chandrasekera, Bryan J Berube, Gauri Shetye, et al.
Scientific Reports|September 1, 2022
Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screeningAnuradha Kumar, Somsundaram Chettiar, Brian S Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complexHacer Guvenc, Marat S Pavlyukov, Kaushal Joshi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|November 1, 2016
Current challenges in drug discovery for tuberculosisAnuradha Kumar, Somsundaram Chettiar, Tanya Parish
Access Microbiology|September 25, 2020
Cell wall inhibitors increase the accumulation of rifampicin in <i>Mycobacterium tuberculosis</i>Matthew B McNeil, Somsundaram Chettiar, Divya Awasthi, et al.
Anticancer Research|May 29, 2017
Structure-Activity Relationship of Niclosamide DerivativesZhonghai Tang, Ulyana Muñoz Acuña, Nelson Freitas Fernandes, et al.
Microbiology Spectrum|January 23, 2023
Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosisShilah Bonnett, Jo-Ann Jee, Somsundaram Chettiar, et al.
Bioorganic & Medicinal Chemistry|March 6, 2017
Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancerYasuro Sugimoto, Dwitiya B Sawant, Harold A Fisk, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2015
Niclosamide Analogs for Treatment of Ovarian CancerChristen L Walters Haygood, Rebecca C Arend, Abhishek Gangrade, et al.
ACS Infectious Diseases|October 17, 2017
Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrBN Susantha Chandrasekera, Bryan J Berube, Gauri Shetye, et al.
Scientific Reports|September 1, 2022
Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screeningAnuradha Kumar, Somsundaram Chettiar, Brian S Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complexHacer Guvenc, Marat S Pavlyukov, Kaushal Joshi, et al.
Pageof 1